Company Search:
Advanced Search
Sponsored Links
Ocera Therapeutics Inc Company Snapshot
Ocera Therapeutics Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ocera Therapeutics Inc with three other companies in this sector in the United States: Eyegate Pharmaceuticals Inc (2016 sales of $669,259.00 ), Dyadic International, Inc. ($592,886.00 ), and Ovascience Inc ($653,000.00 of which 100% was Diagnostic Substance).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Ocera Therapeutics Inc were $609,000.00 . This is an increase of 357.9% versus 2015, when the company's sales were $133,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ocera Therapeutics Inc
  Stock Performance Chart for Ocera Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 1.43
(Figures in U.S. Dollars)
1 Week 2.1%   13 Weeks 121.7%  
4 Weeks -36.4%   52 Weeks -50.9%  
Ocera Therapeutics Inc Key Data:
  Ticker: OCRX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 609,000
(Year Ending Jan 2017).
Employees: 20
  Currency: U.S. Dollars Market Cap: 33,748,346
  Fiscal Yr Ends: December Shares Outstanding: 23,600,242
  Share Type: Common Closely Held Shares: 469,238
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.